Skórska, K.B.; Płaczkowska, S.; Prescha, A.; Porębska, I.; Kosacka, M.; Pawełczyk, K.; Zabłocka-Słowińska, K.
Serum Total SOD Activity and SOD1/2 Concentrations in Predicting All-Cause Mortality in Lung Cancer Patients. Pharmaceuticals 2021, 14, 1067.
https://doi.org/10.3390/ph14111067
AMA Style
Skórska KB, Płaczkowska S, Prescha A, Porębska I, Kosacka M, Pawełczyk K, Zabłocka-Słowińska K.
Serum Total SOD Activity and SOD1/2 Concentrations in Predicting All-Cause Mortality in Lung Cancer Patients. Pharmaceuticals. 2021; 14(11):1067.
https://doi.org/10.3390/ph14111067
Chicago/Turabian Style
Skórska, Katarzyna Beata, Sylwia Płaczkowska, Anna Prescha, Irena Porębska, Monika Kosacka, Konrad Pawełczyk, and Katarzyna Zabłocka-Słowińska.
2021. "Serum Total SOD Activity and SOD1/2 Concentrations in Predicting All-Cause Mortality in Lung Cancer Patients" Pharmaceuticals 14, no. 11: 1067.
https://doi.org/10.3390/ph14111067
APA Style
Skórska, K. B., Płaczkowska, S., Prescha, A., Porębska, I., Kosacka, M., Pawełczyk, K., & Zabłocka-Słowińska, K.
(2021). Serum Total SOD Activity and SOD1/2 Concentrations in Predicting All-Cause Mortality in Lung Cancer Patients. Pharmaceuticals, 14(11), 1067.
https://doi.org/10.3390/ph14111067